Intuitive Surgical, Inc.
This article was originally published in The Gray Sheet
Executive Summary
Developer of the da Vinci tele-robotic endoscopic surgical system goes public via initial offering of 5 mil. shares at $9 each on June 13. The $45 mil. total is considerably less than the $115 mil. originally anticipated in a March filing with the Securities and Exchange Commission (1"The Gray Sheet" April 3, p. 21). The Mountain View, California firm will use a portion of the proceeds to facilitate sales force expansion and R&D activity. The shares trade on the Nasdaq exchange under the symbol "ISRG." Underwriters Lehman Brothers, Bear Stearns, FleetBoston Robertson Stephens, UBS Warburg and Fidelity Capital Markets have a 30-day option to purchase up to 750,000 additional shares to cover over-allotments. Separately, Intuitive Surgical announces June 19 the "world's first" totally endoscopic radical prostatectomy with the da Vinci system, at Frankfurt University Hospital, Germany
You may also be interested in...
Intuitive Surgical $115 Mil. IPO Will Help Expand Sales Force, R&D Activity
Intuitive Surgical intends to "significantly increase" its 20-person sales force with proceeds from a planned $115 mil. initial public offering as the firm gears up for FDA approval of its da Vinci tele-robotic endoscopic surgical system for use in sharps laparoscopic surgery.
Fenty Cleanser Performance Claims Supported, But Influencer Videos Need Disclaimers – NAD
A National Advertising Division review of claims by LVMH-owned Fenty Skin determined makeup- and dirt-removal representations were substantiated by a study and subject questionnaire, but demo videos from paid endorsers must include disclosures about material connections in accordance with FTC guidelines.
Clinical Trial Diversity Requires Sponsors Work With An Assortment Of Patient Advocates, Community Organizations
US FDA oncology officials are concerned that the entities sponsors are consulting in developing and implementing clinical trial diversity plans are not sufficiently diverse themselves and do not represent patients in underserved communities.